Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03191812 · ClinicalTrials.gov registry record · NA

The Short-term Effects of Noninvasive Electrical Brain Stimulation on Dual Tasking in Older Adults

A NA study of Aging, sponsored by Hebrew SeniorLife.

Completed
Registry status
NA
Development phase
61
Enrollment target
2
Study locations

NCT03191812: Completed NA study of Aging, sponsored by Hebrew SeniorLife.

NCT03191812 is a NA study of Aging that has completed, run by Hebrew SeniorLife. The registered enrollment target is 61 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03191812, a NA study of Aging, has completed, sponsored by Hebrew SeniorLife.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target
2
Study locations

Study Summary

The tDCS \& Dual Tasking study will compare the effects of transcranial Direct Current Stimulation (tDCS) targeting three different cortical regions (as well as sham stimulation) on dual task standing and walking in older adults with and without a recent history of recurrent falls.

Primary Outcome

The dual task cost to standing postural sway speed will be calculated from trials of standing with and without simultaneous performance of a serial subtraction cognitive task. The dual task cost will be calculated as the percent change in sway speed from single- to dual-task conditions.

Conditions Studied

Interventions

  • OTHER transcranial Direct Current Stimulation (tDCS)

Study Locations (2)

Massachusetts

  • Hebrew Rehabilitation Center - Roslindale

Other

  • Laboratory for Gait and Neurodynamics, Tel Aviv Sourasky Medical Center - Tel Aviv

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2017-05-26
Est. Completion 2021-05-26
Phase NA
Hebrew SeniorLife

32 total trials

What the finished NCT03191812 record still lists

NCT03191812 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which transcranial Direct Current Stimulation (tDCS) is the first listed.

NCT03191812 reports a single indexed study location in Massachusetts, Other.

Frequently Asked Questions

What is clinical trial NCT03191812 about?

NCT03191812 is a clinical study titled "The Short-term Effects of Noninvasive Electrical Brain Stimulation on Dual Tasking in Older Adults". The tDCS \& Dual Tasking study will compare the effects of transcranial Direct Current Stimulation (tDCS) targeting three different cortical regions (as well as sham stimulation) on dual task standing and walking in older adults with and without a recent history of recurrent falls.

What is the current status of trial NCT03191812?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2017-05-26. Estimated completion is 2021-05-26.

What conditions does trial NCT03191812 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT03191812?

The interventions under investigation include: transcranial Direct Current Stimulation (tDCS) (OTHER).

Who is sponsoring clinical trial NCT03191812?

This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03191812 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03191812's enrollment target sits among peer trials

61 135th of 262 higher than 127 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03191812, the US trial registry maintained by the National Library of Medicine. NCT03191812 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.